Janus Henderson Group PLC Regeneron Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 100,424 shares of REGN stock, worth $83.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

100,424

Previous 103,992 3.43%

Holding current value

$83.2 Million

Previous $100 Million 5.45%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $3.15 Million - $3.82 Million	-3,568 Reduced 3.43%	100,424 $106 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $7.98 Million - $8.78 Million	-8,837 Reduced 7.83%	103,992 $100 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $7.43 Million - $8.45 Million	-9,584 Reduced 7.83%	112,829 $99.1 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $24.3 Million - $29.7 Million	35,120 Added 40.23%	122,413 $101 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $76.8 Million - $91.2 Million	-109,778 Reduced 55.7%	87,293 $62.7 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $34 Million - $41.3 Million	-49,951 Reduced 20.22%	197,071 $162 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $27 Million - $29.3 Million	-38,251 Reduced 13.41%	247,022 $178 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $74.5 Million - $94 Million	129,754 Added 83.43%	285,273 $197 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $7.23 Million - $9.74 Million	-13,183 Reduced 7.81%	155,519 $91.9 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $6.12 Million - $7.18 Million	-10,276 Reduced 5.74%	168,702 $118 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $10.1 Million - $12.5 Million	-18,668 Reduced 9.45%	178,978 $113 Million
Q3 2021 Nov 16, 2021	SELL	$574.03 - $680.96 $5.91 Million - $7.01 Million	-10,300 Reduced 4.95%	197,646 $120 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $12.5 Million - $14.7 Million	-26,381 Reduced 11.26%	207,946 $116 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $65.9 Million - $80.9 Million	-147,496 Reduced 38.63%	234,327 $111 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $19.2 Million - $24.5 Million	40,236 Added 11.78%	381,823 $184 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $25.4 Million - $30.7 Million	46,572 Added 15.79%	341,587 $191 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $127 Million - $166 Million	257,084 Added 677.77%	295,015 $184 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $3.15 Million - $4.63 Million	9,363 Added 32.77%	37,931 $18.5 Million
Q4 2019 Feb 18, 2020	SELL	$274.13 - $376.51 $55.7 Million - $76.5 Million	-203,166 Reduced 87.67%	28,568 $10.7 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $18.2 Million - $21.1 Million	-66,398 Reduced 22.27%	231,734 $64.3 Million
Q2 2019 Jul 31, 2019	SELL	$299.6 - $414.82 $39.6 Million - $54.8 Million	-132,020 Reduced 30.69%	298,132 $93.3 Million
Q1 2019 Apr 30, 2019	SELL	$372.08 - $439.57 $188 Million - $222 Million	-505,998 Reduced 54.05%	430,152 $177 Million
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $203 Million - $244 Million	-605,891 Reduced 39.29%	936,150 $350 Million
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $91.5 Million - $106 Million	-260,699 Reduced 14.46%	1,542,041 $623 Million
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $57.9 Million - $70.1 Million	203,306 Added 12.71%	1,802,740 $622 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $23.5 Million - $29.3 Million	-74,406 Reduced 4.45%	1,599,434 $551 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $46.1 Million - $60.4 Million	128,510 Added 8.32%	1,673,840 $629 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $7.61 Million - $8.89 Million	-17,640 Reduced 1.13%	1,545,330 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,562,970	1,562,970 $768 Million

Others Institutions Holding REGN

# of Institutions

1,494

Shares Held

84.9M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Regeneron Pharmaceuticals, Inc. Transaction History